Related Experiment Video
Updated: Aug 12, 2026

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay
Published on: January 26, 2019
Reversible neutropenia during a cold: possible involvement of risperidone? A case report
C Meylan1, G Bondolfi, A C Aubert
1Département Universitaire de Psychiatrie Adulte (DUPA), Hôpital de Cery, Prilly-Lausanne, Switzerland.
Abstract:
After 9 days of risperidone therapy (2-6 mg/day), a 24-year-old schizophrenic female patient developed a leucopenia with neutropenia < 1000/mm3. A few days after starting the neuroleptic treatment, she suffered from a cold, without fever. All immunological tests performed yielded negative results except for influenza B virus. The cessation of the risperidone therapy was followed within 48 h by a normalisation of the WBC differential count. Therefore, in the absence of a rechallenge with risperidone for ethical reasons, it cannot be excluded that risperidone represents at least a partial cause of the observed neutropenia.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Drug Toxicity: Risk factors
Drug Toxicity: Allergic Reactions
Respiratory Syncytial Virus Disease
